Tomoji Nishioka
Overview
Explore the profile of Tomoji Nishioka including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
150
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Komichi D, Tazuma S, Nishioka T, Hyogo H, Chayama K
Free Radic Biol Med
. 2005 Nov;
39(11):1418-27.
PMID: 16274877
Bile acids have been suggested to be involved in biliary carcinogenesis, although the underlying mechanisms are yet to be established. The aim of this study was to investigate the carcinogenic...
2.
Numata Y, Tazuma S, Ueno Y, Nishioka T, Hyogo H, Chayama K
Dig Dis Sci
. 2005 Sep;
50(10):1844-51.
PMID: 16187185
Primary sclerosing cholangitis is often complicated by ulcerative colitis. Recently, we reported on Th1-dominant cholangitis associated with experimental colitis, and natural killer T (NKT) cells might play an important role...
3.
Nishioka T, Hyogo H, Numata Y, Yamaguchi A, Kobuke T, Komichi D, et al.
J Atheroscler Thromb
. 2005 Sep;
12(4):211-7.
PMID: 16141625
Fibrates are commonly used lipid-lowering agents that act via PPARalpha, a member of the nuclear hormone receptor superfamily. The mechanism(s) of fibrate-induced changes in the hepatic canalicular membrane and bile...
4.
Yamaguchi A, Tazuma S, Nishioka T, Ohishi W, Hyogo H, Nomura S, et al.
Dig Dis Sci
. 2005 Jul;
50(7):1361-71.
PMID: 16047488
We studied the roles of hepatitis C virus (HCV) core protein in hepatic steatosis and changes in hepatic lipid metabolism. HCV core protein expression plasmid was transfected in HepG2. Triacylglyceride...
5.
Kanno K, Tazuma S, Nishioka T, Hyogo H, Chayama K
Dig Dis Sci
. 2005 May;
50(5):942-8.
PMID: 15906773
In this study, we assessed the hypothesis that angiotensin (Ang) II could modulate inflammatory cell recruitment into the liver through hepatic expression of monocyte chemoattractant protein (MCP)-1 during liver injury....
6.
Komichi D, Tazuma S, Nishioka T, Hyogo H, Chayama K
Dig Dis Sci
. 2005 Apr;
50(3):514-24.
PMID: 15810635
Bile acids are considered to be involved in the development of biliary tract carcinoma, although the underlying mechanisms are yet to be established. The aims of this study were (1)...
7.
Tsuboi K, Tazuma S, Nishioka T, Chayama K
J Gastroenterol
. 2004 Nov;
39(10):955-60.
PMID: 15549448
Background: We recently demonstrated that cyclosporine A causes a disproportionate reduction of biliary lipid secretion, and this is inhibited by hydrophilic bile salts through the enhancing of biliary lecithin secretion....
8.
Nishioka T, Chayama K
Nihon Rinsho
. 2004 Sep;
62 Suppl 7(Pt 1):195-8.
PMID: 15359792
No abstract available.
9.
Numata Y, Tazuma S, Nishioka T, Ueno Y, Chayama K
J Gastroenterol Hepatol
. 2004 Jul;
19(8):910-5.
PMID: 15242495
Background And Aim: Primary sclerosing cholangitis is frequently complicated by inflammatory bowel disease. Although many colitis models have been reported, little information has been obtained about complicated cholangitis. The aim...
10.
Nishioka T, Having R, Tazuma S, Stellaard F, Kuipers F, Verkade H
Biochim Biophys Acta
. 2004 May;
1636(2-3):90-8.
PMID: 15164756
Background And Aims: Intestinal bile deficiency in cholestatic patients leads to fat malabsorption. We addressed the potency of model bile, bile salts and phosphatidylcholine (PC)-cholesterol (CH) liposomes to reconstitute fat...